Additionally, the study confirmed that the activity of AURKA mRNA IRES was elevated in G2/M phase compared to G1/S phase in a cancer cell line (see above) and showed that the AURKA mRNA 5′UTR variants containing exon II bore stronger IRES activity than the variants containing exon I only. This evidence concerns the gene AURKA and cancer.